MedTrace Logo

Lung Ultrasound for Acute Dyspnea in Emergency Department

NCT01287429 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1005

Last updated 2012-11-20

No results posted yet for this study

Summary

Dyspnea is a frequent symptom in patients admitted to the Emergency Department (ED); discriminating between cardiogenic and non-cardiogenic dyspnea is a common clinical dilemma. The initial diagnostic work-out is often not very accurate in defining the etiology and the underlying pathophysiology. In the last years, lung ultrasound (US) has emerged as a useful real-time bedside diagnostic tool in the critical patient. The aim of this study was to evaluate the accuracy, reproducibility, and diagnostic impact of pleural and lung US, performed by emergency physicians at the time of patient first presentation to the ED, in identifying cardiac causes of acute dyspnea.

Conditions

Interventions

OTHER

lung and pleural ultrasound

After the initial diagnostic work-out (medical history, physical examination, EKG, arterious blood gas), the emergency physician will classify dyspnoea in cardiogenic or respiratory dyspnoea and write it down in a specific form (clinical form). Immediately after this, lung and pleural ultrasound will be performed: the physician will describe it and evaluate the etiology again (integrated evaluation form). Then a chest X-ray evaluation will be performed for each patient.

Sponsors & Collaborators

  • Azienda Ospedaliera San Giovanni Battista

    collaborator OTHER

  • San Luigi Gonzaga Hospital

    collaborator OTHER

  • Agnelli Hospital, Italy

    collaborator OTHER

  • Azienda Ospedaliera Ordine Mauriziano di Torino

    collaborator OTHER

  • Martini Hospital, Turin, Italy

    collaborator OTHER

  • Ospedale Cardinal Massaia

    collaborator OTHER

  • Ospedale Santa Croce-Carle Cuneo

    collaborator OTHER

  • University of Turin, Italy

    lead OTHER

Principal Investigators

  • Emanuele Pivetta · Cancer Epidemiology Unit - University of Turin

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2012-10-31
Completion
2012-10-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01287429 on ClinicalTrials.gov